BioCryst Pharmaceuticals, Inc. (BCRX)

NASDAQ: BCRX · Real-Time Price · USD

8.76

-0.25 (-2.77%)

At close: Apr 23, 2026, 4:00 PM EDT

8.71

-0.05 (-0.57%)

Pre-market: Apr 24, 2026, 7:23 AM EDT

BioCryst Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	874.84	450.71	331.41	270.83	157.17
Revenue Growth (YoY)	94.10%	36.00%	22.37%	72.31%	782.38%
Cost of Revenue	19.08	12.27	4.48	6.41	7.23
Gross Profit	855.76	438.44	326.93	264.42	149.94
Selling, General & Admin	348.65	266.35	214.07	159.37	118.82
Research & Development	166.13	174.64	216.57	253.3	208.81
Other Operating Expenses	-	-	-	0.19	0.04
Total Operating Expenses	514.77	440.99	430.64	412.85	327.66
Operating Income	340.99	-2.54	-103.71	-148.44	-177.72
Interest Income	10.67	14.75	15.78	5.13	0.06
Interest Expense	-78.87	-98.52	-108.24	-99.09	-59.29
Other Non-Operating Income (Expense)	-5.39	-0.64	-30.06	-1.98	55.14
Total Non-Operating Income (Expense)	-73.6	-84.41	-122.52	-95.95	-4.09
Pretax Income	267.39	-86.95	-226.23	-244.38	-181.81
Provision for Income Taxes	3.53	1.93	0.31	2.73	2.25
Net Income	263.86	-88.88	-226.54	-247.12	-184.06
Net Income to Common	263.86	-88.88	-226.54	-247.12	-184.06
Shares Outstanding (Basic)	210	207	192	186	179
Shares Outstanding (Diluted)	219	207	192	186	179
Shares Change (YoY)	5.75%	7.54%	3.38%	3.79%	7.08%
EPS (Basic)	1.26	-0.43	-1.18	-1.33	-1.03
EPS (Diluted)	1.21	-0.43	-1.18	-1.33	-1.03
Shares Outstanding	213.06	208.54	205.77	187.91	184.35
Free Cash Flow	344.9	-53.14	-97.31	-163.1	-144.54
Free Cash Flow Per Share	1.58	-0.26	-0.51	-0.88	-0.81
Gross Margin	97.82%	97.28%	98.65%	97.63%	95.40%
Operating Margin	38.98%	-0.56%	-31.29%	-54.81%	-113.07%
Profit Margin	30.16%	-19.72%	-68.36%	-91.25%	-117.11%
FCF Margin	39.42%	-11.79%	-29.36%	-60.22%	-91.97%
EBITDA	342.38	-1.3	-102.05	-147	-176.94
EBITDA Margin	39.14%	-0.29%	-30.79%	-54.28%	-112.58%
EBIT	340.99	-2.54	-103.71	-148.44	-177.72
EBIT Margin	38.98%	-0.56%	-31.29%	-54.81%	-113.07%
Effective Tax Rate	1.32%	-2.22%	-0.14%	-1.12%	-1.24%

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q